(PDF) Effective Management of COPD in Primary Care

Effective Management of COPD in Primary Care — The Role of Long-Acting Beta Agonist/Inhaled Corticosteroid Combination Therapy

Primary Care Respiratory Journal

doi 10.1016/j.pcrj.2006.02.007

Full Text

Open PDF

Abstract

Available in full text

Date

June 1, 2006

Authors

C.P. (Onno) van Schayck

Jim Reid

Publisher

Springer Nature

Related search

Effects of Roflumilast in COPD Patients Receiving Inhaled Corticosteroid/Long-Acting Β2-Agonist Fixed-Dose Combination: RE2SPOND Rationale and Study Design

International Journal of COPD

English

Severe Exacerbation and Pneumonia in COPD Patients Treated With Fixed Combinations of Inhaled Corticosteroid and Long-Acting Beta2 Agonist

International Journal of COPD

English

The Inhaled Corticosteroid/Long-Acting Β-Agonist Maintenance and Reliever Therapy Regimen: Where to From Here?

European Respiratory Journal

English

PRS30 Inhaled Corticosteroid and Long-Acting Beta-Agonist Medication Compliance in Patients With Moderate and Severe Asthma

English

Inhaled Short Acting Beta Agonist Use in COPD and the Risk of Acute Myocardial Infarction

English

P124 a Randomised, Parallel-Group Study to Evaluate the Effect of Umeclidinium Added to Inhaled Corticosteroid/Long-Acting Beta-Agonist Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease: Abstract P124 Table 1

English

Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist

Pulmonary Therapy

2016

English

Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD

English

Combination Inhaled Steroid and Long-Acting Beta2-Agonist Versus Tiotropium for Chronic Obstructive Pulmonary Disease

2010

English

Amanote Research

Effective Management of COPD in Primary Care — The Role of Long-Acting Beta Agonist/Inhaled Corticosteroid Combination Therapy

Primary Care Respiratory Journal

doi 10.1016/j.pcrj.2006.02.007

Full Text

Abstract

Date

Authors

Publisher

Related search

Effects of Roflumilast in COPD Patients Receiving Inhaled Corticosteroid/Long-Acting &Beta;2-Agonist Fixed-Dose Combination: RE2SPOND Rationale and Study Design

Severe Exacerbation and Pneumonia in COPD Patients Treated With Fixed Combinations of Inhaled Corticosteroid and Long-Acting Beta2 Agonist

The Inhaled Corticosteroid/Long-Acting Β-Agonist Maintenance and Reliever Therapy Regimen: Where to From Here?

PRS30 Inhaled Corticosteroid and Long-Acting Beta-Agonist Medication Compliance in Patients With Moderate and Severe Asthma

Inhaled Short Acting Beta Agonist Use in COPD and the Risk of Acute Myocardial Infarction

P124 a Randomised, Parallel-Group Study to Evaluate the Effect of Umeclidinium Added to Inhaled Corticosteroid/Long-Acting Beta-Agonist Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease: Abstract P124 Table 1

Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist

Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD

Combination Inhaled Steroid and Long-Acting Beta2-Agonist Versus Tiotropium for Chronic Obstructive Pulmonary Disease

Effects of Roflumilast in COPD Patients Receiving Inhaled Corticosteroid/Long-Acting Β2-Agonist Fixed-Dose Combination: RE2SPOND Rationale and Study Design